HIPK2 overexpression reduces the basal levels of HIF-1α with a mechanism that does not involve hypoxia, inhibiting the HIF-1 transcriptional activity and, therefore, counteracting theHIF-1-induced angiogenesis and tumor progression, in vitro and in vivo [51,71,72,73]. The gene discussed is HIPK2; the disease is neoplasm.